A. Batova

666 total citations
12 papers, 527 citations indexed

About

A. Batova is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, A. Batova has authored 12 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Oncology. Recurrent topics in A. Batova's work include Neuroblastoma Research and Treatments (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). A. Batova is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). A. Batova collaborates with scholars based in United States, Hong Kong and Italy. A. Batova's co-authors include Alice L. Yu, Tsutomu Nobori, John Yu, Lucia Pirisi, Kim E. Creek, Motoko Omura‐Minamisawa, Phuoc T. Tran, K Takabayashi, D A Carson and Mitchell B. Diccianni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

A. Batova

12 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Batova United States 10 340 161 97 84 62 12 527
Lippman Sm United States 9 346 1.0× 221 1.4× 56 0.6× 72 0.9× 165 2.7× 16 807
Rudi Henriksen Sweden 9 276 0.8× 223 1.4× 94 1.0× 106 1.3× 76 1.2× 15 643
Yoko Hasumi Japan 14 242 0.7× 133 0.8× 85 0.9× 76 0.9× 28 0.5× 29 521
Kenji Tatsuno Japan 11 317 0.9× 138 0.9× 110 1.1× 100 1.2× 44 0.7× 24 573
Junji Koya Japan 13 291 0.9× 89 0.6× 92 0.9× 93 1.1× 49 0.8× 35 523
Jane Ramsdale United Kingdom 6 237 0.7× 183 1.1× 54 0.6× 62 0.7× 59 1.0× 8 436
Sandra D. Bohling United States 13 209 0.6× 211 1.3× 33 0.3× 63 0.8× 141 2.3× 22 586
M Allouche France 12 303 0.9× 124 0.8× 48 0.5× 46 0.5× 118 1.9× 25 583
Laure Vincent France 17 439 1.3× 179 1.1× 31 0.3× 93 1.1× 66 1.1× 58 802
J. Graham Sharp United States 12 181 0.5× 250 1.6× 26 0.3× 83 1.0× 113 1.8× 26 633

Countries citing papers authored by A. Batova

Since Specialization
Citations

This map shows the geographic impact of A. Batova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Batova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Batova more than expected).

Fields of papers citing papers by A. Batova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Batova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Batova. The network helps show where A. Batova may publish in the future.

Co-authorship network of co-authors of A. Batova

This figure shows the co-authorship network connecting the top 25 collaborators of A. Batova. A scholar is included among the top collaborators of A. Batova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Batova. A. Batova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Batova, A., et al.. (2004). Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma. Journal of Clinical Oncology. 22(14_suppl). 8511–8511. 5 indexed citations
3.
Omura‐Minamisawa, Motoko, Mitchell B. Diccianni, Ray Chang, et al.. (2001). p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.. PubMed. 7(11). 3481–90. 45 indexed citations
4.
Omura‐Minamisawa, Motoko, Mitchell B. Diccianni, A. Batova, et al.. (2000). Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.. PubMed. 6(4). 1219–28. 37 indexed citations
5.
Wong, Y.F., Tony K.H. Chung, Tak Hong Cheung, et al.. (1999). Methylation of p16 in primary gynecologic malignancy. Cancer Letters. 136(2). 231–235. 69 indexed citations
6.
Batova, A., Motoko Omura‐Minamisawa, John Yu, et al.. (1999). Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.. PubMed. 59(7). 1492–7. 44 indexed citations
7.
Batova, A., et al.. (1999). The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.. PubMed. 5(12). 4259–63. 41 indexed citations
8.
Yu, John, et al.. (1997). Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.. PubMed. 3(3). 433–8. 23 indexed citations
10.
Nobori, Tsutomu, K Takabayashi, Phuoc T. Tran, et al.. (1996). Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.. Proceedings of the National Academy of Sciences. 93(12). 6203–6208. 93 indexed citations
11.
Batova, A., et al.. (1994). Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.. PubMed. 5(5). 537–47. 33 indexed citations
12.
Pirisi, Lucia, et al.. (1992). Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.. PubMed. 52(1). 187–93. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026